XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Incentive Plan (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity under the stock incentive plans since December 31, 2021:

 

 

 

 

Number of Options

 

 

Weighted-
Average
Exercise Price
(per Share)

 

 

Weighted-
Average
Remaining
Contract Term
(in Years)

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

5,322,314

 

 

$

6.75

 

 

 

 

Exercisable at December 31, 2021

 

 

3,296,183

 

 

 

3.03

 

 

 

 

 

Granted

 

 

4,001,890

 

 

 

7.56

 

 

 

 

 

Exercised

 

 

(65,399

)

 

 

0.62

 

 

 

 

 

Canceled or forfeited

 

 

(119,461

)

 

 

17.83

 

 

 

 

Outstanding at March 31, 2022

 

 

9,139,344

 

 

 

7.00

 

 

 

9.01

 

Exercisable at March 31, 2022

 

 

3,365,635

 

 

 

3.08

 

 

 

7.81

 

Summary of Equity Based Compensation Expense

The classification of stock-based compensation expense is summarized as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Research and development

 

$

909

 

 

$

225

 

Selling, general and administrative

 

 

2,657

 

 

 

871

 

Total stock-based compensation expense

 

$

3,566

 

 

$

1,096

 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table shows the weighted-average assumptions used to compute the fair value of the awards granted to employees and nonemployees using the Black-Scholes option pricing model during the periods below:

 

 

 

Three Months Ended March 31,

Assumption

 

2022

 

2021

Expected volatility

 

56.87%

 

82.50%

Expected term (years)

 

5.86.1

 

6.06.1

Expected dividend yield

 

0.00%

 

0.00%

Risk-free interest rate

 

1.67%

 

0.87%

Forfeiture rate

 

0.00%

 

0.00%

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following as of March 31, 2022:

 

Stock options issued and outstanding under all Plans

 

 

9,139,344

 

Authorized for future grants under the 2021 Plan

 

 

7,006,507

 

Authorized for future grants under the ESPP

 

 

1,394,991

 

Total as of March 31, 2022

 

 

17,540,842